Lv6
1750 积分 2021-08-17 加入
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
2天前
已完结
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer
18天前
已完结
Cyclin E, a Potential Prognostic Marker in Breast Cancer
1个月前
已关闭
Deregulation of cyclin E in breast cancer
1个月前
已关闭
Processing of cyclin E differs between normal and tumor breast cells
1个月前
已关闭
CDK3 induces neuronal death and brain atrophy in Alzheimer’s disease
1个月前
已完结
An overview of CDK3 in cancer: clinical significance and pharmacological implications
1个月前
已完结
Advancing targeted protein degradation for cancer therapy
2个月前
已完结
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers
2个月前
已完结
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
2个月前
已完结
皖公网安备34019202002308
